Search PubMed⌕ Search

PubMed · 9510705

Using a supervisory framework to support and evaluate a multiproject practice development programme.

Abstract

The paper describes a multiproject practice development programme undertaken over a period of 1 year. The background and development of the programme are outlined, whilst attention is paid to the innovatory nature of the work, particularly the use of inductive, deductive and integrated approaches to both change implementation and project supervision. The programme was monitored throughout using different data sources and the paper uses evaluative material retrospectively to provide answers to organizational and professional difficulties which arose during the course of the programme. The authors conclude that the use of combinations of different models for practice development has potential, but requires careful supervision. They also recommend that those involved in practice development are made fully aware of its local or micropolitics, and develop strategies to deal with change before it occurs, not after it has taken place.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

M F Ward, A Titchen, C Morrell, B McCormack, A Kitson. 1998. Using a supervisory framework to support and evaluate a multiproject practice development programme.. https://doi.org/10.1046/j.1365-2702.1998.00135.x

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

[Acute and transient psychotic disorders (ICD-10: F23). Empirical data and implications for therapy].

The defining clinical features of acute and transient psychotic disorders (ICD-10: F23) are an acute onset and a duration of psychotic symptoms not exceeding 1-3 months. Previous empirical investigations show that patients with this diagnosis have a favourable prognosis, but also a high risk of relapses (58-77%). The diagnostic stability in the further course of illness seems to be low (34-73%) with a frequent diagnostic change to schizophrenia and affective disorders being observed. As yet, data from controlled clinical trials regarding therapy do not exist. The implications for the treatment of acute and transient psychotic disorders are discussed with this background.

Evidence-Based Medicine↗